Searched for
GAMALEYA
Cancer cure? Russia commences human trials of revolutionary personalized cancer vaccineRussia's Gamaleya Center, famed for Sputnik V, will initiate human trials for a personalized mRNA melanoma vaccine by late 2025. This innov...- Two doses of Sputnik provide two times higher antibodies against Omicron than Pfizer vaccine: StudyThe study was conducted at the Italian Spallanzani Institute on comparable groups of sera from individuals vaccinated with Sputnik V and Pf...
- Sputnik V protects two times more against Covid than Pfizer's vaccine: StudySputnik V in a statement on Thursday said that as per an independent comparative study conducted by the Spallanzani institute in Italy, its...
- Sputnik Light booster works against OmicronGamaleya said it expects Sputnik V to provide a strong defence against severe disease and hospitalisation, as the drop in neutralising acti...
- Omicron variant could replace Delta strain globally: Head of Russian Gamaleya InstituteAccording to the Gamaleya institute director, the effectiveness of the Russian Sputnik V vaccine against the Omicron strain will be tested ...
- European efforts to assess Russia’s Sputnik V vaccine stymied by data gapsSeparately, an assessment of Sputnik V by a French delegation of scientists in advance of the EMA review found that the vaccine developers ...
- Gap between Sputnik V COVID-19 shots can be up to 180 days - Russia's RDIFAn official at the RDIF, which markets the vaccine abroad, made the comments in a statement after some countries decided to widen the gap b...
- Panacea gets approval to make Sputnik V at its Himachal PlantNew Delhi-based Panacea Biotech has a collaboration with Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund which is bac...
- Serum Institute gets DCGI's nod to manufacture Sputnik V in India for test, analysis"The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test and anal...
- Russia repeats 91.4% efficacy rate in new COVID-19 vaccine data: DevelopersThe new results are based on data from 22,714 participants in the trial, and were published after 78 confirmed coronavirus cases were repor...
- AstraZeneca to test combining COVID-19 vaccine with Russian shotThe developers of Sputnik V suggested on Twitter last month that AstraZeneca try the combination.
- Russia says Sputnik V virus vaccine 95% effectiveThe calculations were based on preliminary data obtained 42 days after the first dose, Russia's health ministry, the state-run Gamaleya res...
- How Russia shortened the Covid vaccine race in rush to declare victoryThe vaccine will be ready for wide distribution late this year or early next, officials say. That's roughly the same schedule as shots from...
- Russia looking for partnership with India for producing COVID-19 vaccine Sputnik: RDIF CEOSputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology, along with the RDIF. The vaccine has not ...
- Indian pharma producers show great interest in Covid-19 vaccine Sputnik V: Russian sovereign wealth fundThe RDIF has funded research and production of Sputnik V, the world’s first approved coronavirus vaccine, developed by the Moscow-based Gam...
- Russia not world's first to develop coronavirus vaccine: Kiran Mazumdar-ShawThe world has not seen any data on Phase 1 or 2 clinical trials conducted by Moscow-based Gamaleya Research Institute, the Executive Chairp...
- Russia plans to register the world's first coronavirus vaccine on August 12"The vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, third, stage is underway. The trial...
- Russia aims to launch mass production of coronavirus vaccine doses by 2021The country is pushing ahead with several vaccine prototypes and one trialled by the Gamaleya institute in Moscow has reached advanced stag...
- Search for solution: Russia plans to register first coronavirus vaccine by August 12The drug developed by Moscow’s Gamaleya Institute and the Russian Direct Investment Fund may be approved for civilian use within three to s...
- Russian sovereign wealth fund in touch with India to share advanced practices on Covid vaccine: CEO"RDIF is cooperating with Indian partners to share the most advanced practices to combat coronavirus, we have been in touch through the who...
Load More
